AAPL351.98-4.30 (-1.21%) ▼|ABBV294.62-0.41 (-0.14%) ▼|ABT108.39-0.13 (-0.12%) ▼|ACN251.40+0.91 (+0.36%) ▲|ADBE249.07+5.99 (+2.46%) ▲|AMAT352.20-18.30 (-4.94%) ▼|AMD505.08-28.98 (-5.43%) ▼|AMGN466.92+1.25 (+0.27%) ▲|AMT191.03-0.62 (-0.32%) ▼|AMZN258.50-8.16 (-3.06%) ▼|AVGO331.81-15.20 (-4.38%) ▼|AXP318.55-2.05 (-0.64%) ▼|BA166.14-5.36 (-3.13%) ▼|BAC50.06-0.96 (-1.88%) ▼|BKNG156.95-2.63 (-1.65%) ▼|BLK1,199.56-23.36 (-1.91%) ▼|BMY63.33-0.10 (-0.16%) ▼|BNY151.93-1.48 (-0.96%) ▼|BRK-B593.13+0.19 (+0.03%) ▲|C121.28-2.73 (-2.20%) ▼|CAT574.35-25.85 (-4.31%) ▼|CL101.64+1.97 (+1.98%) ▲|CMCSA25.62+0.46 (+1.83%) ▲|COF192.77-1.51 (-0.78%) ▼|COP140.18-1.17 (-0.83%) ▼|COST1,111.47+5.26 (+0.48%) ▲|CRM216.73-1.11 (-0.51%) ▼|CSCO94.69-0.95 (-0.99%) ▼|CVS88.27-1.08 (-1.21%) ▼|CVX217.25-2.64 (-1.20%) ▼|DE660.11-13.43 (-1.99%) ▼|DHR231.93-1.10 (-0.47%) ▼|DIS118.29-0.68 (-0.57%) ▼|DUK130.38+1.22 (+0.94%) ▲|EMR161.01-5.37 (-3.23%) ▼|FDX326.67+2.53 (+0.78%) ▲|GD359.62-3.84 (-1.06%) ▼|GE326.86-4.95 (-1.49%) ▼|GEV762.96-40.17 (-5.00%) ▼|GILD169.22+1.14 (+0.68%) ▲|GM83.82-2.18 (-2.53%) ▼|GOOG283.67-8.85 (-3.03%) ▼|GOOGL286.53-9.24 (-3.12%) ▼|GS889.70-26.86 (-2.93%) ▼|HD348.19-0.50 (-0.14%) ▼|HON220.06-2.41 (-1.08%) ▼|IBM244.32-2.81 (-1.14%) ▼|INTC55.26-4.41 (-7.38%) ▼|INTU348.99+7.29 (+2.13%) ▲|ISRG441.79-1.80 (-0.41%) ▼|JNJ284.93-0.82 (-0.29%) ▼|JPM338.92-7.27 (-2.10%) ▼|KO99.46+0.21 (+0.21%) ▲|LIN526.32+0.26 (+0.05%) ▲|LLY1,443.31-0.19 (-0.01%) ▼|LMT582.92-13.12 (-2.20%) ▼|LOW226.69-1.05 (-0.46%) ▼|LRCX210.88-15.04 (-6.66%) ▼|MA664.41+3.22 (+0.49%) ▲|MCD276.35+4.38 (+1.61%) ▲|MDLZ68.06+0.52 (+0.76%) ▲|MDT103.30+0.44 (+0.42%) ▲|META624.89-16.80 (-2.62%) ▼|MMM183.26-0.40 (-0.22%) ▼|MO78.81+0.17 (+0.22%) ▲|MRK146.37-1.39 (-0.94%) ▼|MS184.21-6.44 (-3.38%) ▼|MSFT521.11-2.77 (-0.53%) ▼|MU722.39-55.92 (-7.19%) ▼|NEE85.54+0.42 (+0.49%) ▲|NFLX60.87-1.28 (-2.06%) ▼|NKE37.82-0.17 (-0.45%) ▼|NOW100.53-1.72 (-1.69%) ▼|NVDA155.25-7.60 (-4.67%) ▼|ORCL118.96-6.39 (-5.10%) ▼|PEP147.69+2.25 (+1.55%) ▲|PFE28.95+0.06 (+0.19%) ▲|PG173.13+3.33 (+1.96%) ▲|PLTR161.10-6.89 (-4.10%) ▼|PM196.43-2.53 (-1.27%) ▼|QCOM170.86-1.61 (-0.93%) ▼|RTX195.70-2.88 (-1.45%) ▼|SBUX108.04+1.60 (+1.50%) ▲|SCHW93.34+0.36 (+0.38%) ▲|SO94.08+1.25 (+1.35%) ▲|SPG231.12-1.85 (-0.79%) ▼|T22.31+0.13 (+0.56%) ▲|TMO695.19-5.03 (-0.72%) ▼|TMUS171.88+1.93 (+1.14%) ▲|TSLA378.61-11.62 (-2.98%) ▼|TXN295.91-7.70 (-2.53%) ▼|UBER69.67-0.02 (-0.03%) ▼|UNH410.10+2.64 (+0.65%) ▲|UNP304.43+1.99 (+0.66%) ▲|UPS111.29+0.53 (+0.48%) ▲|USB60.44-0.55 (-0.90%) ▼|V427.39+1.63 (+0.38%) ▲|VZ46.43+0.07 (+0.15%) ▲|WFC84.38-1.68 (-1.95%) ▼|WMT128.25+0.16 (+0.12%) ▲|XOM167.38-2.14 (-1.26%) ▼|AAPL351.98-4.30 (-1.21%) ▼|ABBV294.62-0.41 (-0.14%) ▼|ABT108.39-0.13 (-0.12%) ▼|ACN251.40+0.91 (+0.36%) ▲|ADBE249.07+5.99 (+2.46%) ▲|AMAT352.20-18.30 (-4.94%) ▼|AMD505.08-28.98 (-5.43%) ▼|AMGN466.92+1.25 (+0.27%) ▲|AMT191.03-0.62 (-0.32%) ▼|AMZN258.50-8.16 (-3.06%) ▼|AVGO331.81-15.20 (-4.38%) ▼|AXP318.55-2.05 (-0.64%) ▼|BA166.14-5.36 (-3.13%) ▼|BAC50.06-0.96 (-1.88%) ▼|BKNG156.95-2.63 (-1.65%) ▼|BLK1,199.56-23.36 (-1.91%) ▼|BMY63.33-0.10 (-0.16%) ▼|BNY151.93-1.48 (-0.96%) ▼|BRK-B593.13+0.19 (+0.03%) ▲|C121.28-2.73 (-2.20%) ▼|CAT574.35-25.85 (-4.31%) ▼|CL101.64+1.97 (+1.98%) ▲|CMCSA25.62+0.46 (+1.83%) ▲|COF192.77-1.51 (-0.78%) ▼|COP140.18-1.17 (-0.83%) ▼|COST1,111.47+5.26 (+0.48%) ▲|CRM216.73-1.11 (-0.51%) ▼|CSCO94.69-0.95 (-0.99%) ▼|CVS88.27-1.08 (-1.21%) ▼|CVX217.25-2.64 (-1.20%) ▼|DE660.11-13.43 (-1.99%) ▼|DHR231.93-1.10 (-0.47%) ▼|DIS118.29-0.68 (-0.57%) ▼|DUK130.38+1.22 (+0.94%) ▲|EMR161.01-5.37 (-3.23%) ▼|FDX326.67+2.53 (+0.78%) ▲|GD359.62-3.84 (-1.06%) ▼|GE326.86-4.95 (-1.49%) ▼|GEV762.96-40.17 (-5.00%) ▼|GILD169.22+1.14 (+0.68%) ▲|GM83.82-2.18 (-2.53%) ▼|GOOG283.67-8.85 (-3.03%) ▼|GOOGL286.53-9.24 (-3.12%) ▼|GS889.70-26.86 (-2.93%) ▼|HD348.19-0.50 (-0.14%) ▼|HON220.06-2.41 (-1.08%) ▼|IBM244.32-2.81 (-1.14%) ▼|INTC55.26-4.41 (-7.38%) ▼|INTU348.99+7.29 (+2.13%) ▲|ISRG441.79-1.80 (-0.41%) ▼|JNJ284.93-0.82 (-0.29%) ▼|JPM338.92-7.27 (-2.10%) ▼|KO99.46+0.21 (+0.21%) ▲|LIN526.32+0.26 (+0.05%) ▲|LLY1,443.31-0.19 (-0.01%) ▼|LMT582.92-13.12 (-2.20%) ▼|LOW226.69-1.05 (-0.46%) ▼|LRCX210.88-15.04 (-6.66%) ▼|MA664.41+3.22 (+0.49%) ▲|MCD276.35+4.38 (+1.61%) ▲|MDLZ68.06+0.52 (+0.76%) ▲|MDT103.30+0.44 (+0.42%) ▲|META624.89-16.80 (-2.62%) ▼|MMM183.26-0.40 (-0.22%) ▼|MO78.81+0.17 (+0.22%) ▲|MRK146.37-1.39 (-0.94%) ▼|MS184.21-6.44 (-3.38%) ▼|MSFT521.11-2.77 (-0.53%) ▼|MU722.39-55.92 (-7.19%) ▼|NEE85.54+0.42 (+0.49%) ▲|NFLX60.87-1.28 (-2.06%) ▼|NKE37.82-0.17 (-0.45%) ▼|NOW100.53-1.72 (-1.69%) ▼|NVDA155.25-7.60 (-4.67%) ▼|ORCL118.96-6.39 (-5.10%) ▼|PEP147.69+2.25 (+1.55%) ▲|PFE28.95+0.06 (+0.19%) ▲|PG173.13+3.33 (+1.96%) ▲|PLTR161.10-6.89 (-4.10%) ▼|PM196.43-2.53 (-1.27%) ▼|QCOM170.86-1.61 (-0.93%) ▼|RTX195.70-2.88 (-1.45%) ▼|SBUX108.04+1.60 (+1.50%) ▲|SCHW93.34+0.36 (+0.38%) ▲|SO94.08+1.25 (+1.35%) ▲|SPG231.12-1.85 (-0.79%) ▼|T22.31+0.13 (+0.56%) ▲|TMO695.19-5.03 (-0.72%) ▼|TMUS171.88+1.93 (+1.14%) ▲|TSLA378.61-11.62 (-2.98%) ▼|TXN295.91-7.70 (-2.53%) ▼|UBER69.67-0.02 (-0.03%) ▼|UNH410.10+2.64 (+0.65%) ▲|UNP304.43+1.99 (+0.66%) ▲|UPS111.29+0.53 (+0.48%) ▲|USB60.44-0.55 (-0.90%) ▼|V427.39+1.63 (+0.38%) ▲|VZ46.43+0.07 (+0.15%) ▲|WFC84.38-1.68 (-1.95%) ▼|WMT128.25+0.16 (+0.12%) ▲|XOM167.38-2.14 (-1.26%) ▼|
13 C
New York
Monday, November 16, 2026

Tag: development

Changsha uses engineering expertise to engage in BRI

BEIJING, June 21, 2025 /PRNewswire/ -- A report from China Daily Engineering machinery is a specialty of Changsha in Central China's Hunan province and a...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 21, 2025 /PRNewswire/ -- DDB Worldwide, part...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 21, 2025 /PRNewswire/ -- DDB Worldwide, part...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 20, 2025 /PRNewswire/ -- DDB Worldwide, part...

DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years

Omnicom Network Achieves Record Number of Wins in 76-Year History Under Recently Appointed Global Leadership CANNES, France, June 20, 2025 /CNW/ -- DDB Worldwide, part...

Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration

From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major partner in global health science
From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major partner in global health science

Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025

Bagsværd, Denmark, 20 June 2025 – Novo Nordisk announces subcutaneous amycretin data being presented at the American Diabetes Association (ADA) 85th Scientific Sessions in Chicago, US.1 Full results of two clinical trials evaluating the safety, tolerability and weight loss potential of subcutaneous and oral amycretin in people with overweight or obesity were published today in The Lancet medical journal.1,3 Amycretin is the first treatment that combines GLP-1 and amylin receptor agonism biology in a single molecule.

Embrace Active Site Care Patch Becomes First Medical Device Clinically Proven to Significantly Improve Lipohypertrophy (LH) in Insulin-Using Diabetes Patients

Findings from 16-week trial of novel compression patch will be shared for the first time at the 85th Scientific Sessions of the American Diabetes...

Smart Insulin Tech Helps Pregnant Women with Type 1 Diabetes Maintain Target Blood Glucose Levels

Hybrid closed-loop technology effectively helped women stay in target glucose range for longer compared to standard of care CHICAGO, June 20, 2025 /PRNewswire/ -- A...

Stem Cell-Derived Islet Therapies Shown to Reduce the Need for Injectable Insulin

Breakthrough Studies Demonstrate Stem Cell-Based Technologies as a Potential Alternative Treatment for Type 1 Diabetes CHICAGO, June 20, 2025 /PRNewswire/ -- Findings from two studies...

Novo Nordisk advances early-stage obesity medication, amycretin, to phase 3 clinical development based on early-phase clinical trial results in people with obesity or excess...

Both subcutaneous and oral formulations will advance straight to phase 3 development based on completed clinical studies and feedback received from regulatory authorities1,2PLAINSBORO, N.J.,...

Water Instead of Diet Drinks Associated with Two-Fold Rate of Diabetes Remission in Women

New Research Demonstrates Significant Benefits of Simple Dietary Switch for Blood Glucose Control and Long-Term Weight Management CHICAGO, June 20, 2025 /PRNewswire/ -- Consistently replacing...

Novel Artificial Intelligence Models Detect Type 1 Diabetes Risk Before Clinical Onset

New Studies Highlight Machine Learning as Potential Early Risk Detection Strategy CHICAGO, June 20, 2025 /PRNewswire/ -- Developments from two studies highlighting the potential for machine...

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin...

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced two upcoming late-breaking poster presentations at the American Diabetes Association 85th Scientific Sessions, being held from June 20-23 in Chicago, IL.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment